Clinical trials sponsored by EMD Serono Research & Development Institute, Inc.

Phase breakdown

Conditions studied

Recruiting trials led by EMD Serono Research & Development Institute, Inc.

• A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
  NCT07332481 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 18 locations
• A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
  NCT07355218 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 36 locations
• Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
  NCT07360314 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
  NCT07166601 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many trials is EMD Serono Research & Development Institute, Inc. recruiting for?

EMD Serono Research & Development Institute, Inc. is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.